- Home
- Your Messages
-
Smartest Doc
Test your clinical knowledge against other physicians in the USA by taking our FREE daily quiz!
We invite you to take the "Renal cell carcinoma Quiz"
Current Top Players:
1) Dr. Sandeep Chunduri
2) Dr. Hassan Ghazal
3) Dr. Amer Khouri
>> Live LeaderboardNew! PHYSICIAN REVIEW
Assess your general knowledge at the topic level with your personalized scorecard.
Thousands of multiple-choice questions pinpoint your areas of expertise and prep you for exams.
- Physician Jobs (511)
- More
- Other Specialty
Oncology - Side Effects News & Articles
Looking for the latest in oncology clinical literature? You've found the right page. MDLinx Oncology medical editors comb through the top peer-reviewed clinical journals for the articles they think will make a difference to you and your practice. You'll find them organized here by topic including breast, hematologic, thoracic, gastrointestinal and genitourinary cancers. In a matter of minutes, oncologists, oncology nurses, physician assistants and the whole cancer care team can stay current on the literature as it is published.
On this page, you'll also find MDLinx exclusive content, including monthly highlights from our physician editor, D. Scott Cunningham, MD, PhD. We feature clinical pearls as well, from The Smartest Oncologist to oncology topics in The Smartest Pediatrician daily quiz challenges.
Your Unread Messages in Oncology
See All >> Messages include industry-sponsored communications and special communications from MDLinx-
Smartest Doc Challenge
MDLinx
Today Only! We’re helping you prep for your board exams -
D Scott Cunningham MD, PhD
Site Editor, MDLinx
Markers of obesity and inflammation in postmenopausal breast cancer -
Jill Baker
MDLinx Career Center
NPs and PAs play crucial role amid PCP shortage -
MDLinx Reminder
MDLinx
Conference Center Upgraded with New Tools -
MDLinx Top Read
MDLinx
Running from that pile of unread journals?
Articles
Latest (1) Full Text Articles (84) Focus on Pancreas621 Self-reported fatigue: one dimension or more : Lessons from the Functional Assessment of Chronic Illness Therapy—Fatigue (FACIT-F) questionnaire Supportive Care in Cancer, September 1, 2010
622 Radiation-induced sarcoma in patients with nasopharyngeal carcinoma Full Text Cancer, September 1, 2010
623 Interaction of TAp73 and Breast Cancer–Associated Gene 3 Enhances the Sensitivity of Cervical Cancer Cells in Response to Irradiation-Induced Apoptosis Full Text Cancer Research, August 31, 2010
624 Aspirin-Triggered Lipoxin and Resolvin E1 Modulate Vascular Smooth Muscle Phenotype and Correlate with Peripheral Atherosclerosis American Journal of Pathology, August 31, 2010
625 Cytotoxic Chemotherapy-induced Odontalgia: A Differential Diagnosis for Dental Pain Journal of Endodontics, August 31, 2010
626 Is education an effective management strategy for reducing cancer-related fatigue Supportive Care in Cancer, August 31, 2010
627 Single-dose palonosetron for prevention of chemotherapy-induced nausea and vomiting in patients with aggressive non-Hodgkin's lymphoma receiving moderately emetogenic chemotherapy containing steroids Supportive Care in Cancer, August 31, 2010
628 Acute emesis: moderately emetogenic chemotherapy Supportive Care in Cancer, August 26, 2010
629 Unexpected late radiation neurotoxicity following bevacizumab use: a case series Journal of Neuro-Oncology, August 26, 2010
630 Factors associated with cancer-related fatigue in breast cancer patients undergoing endocrine therapy in an urban setting: A cross-sectional study Full Text BMC Cancer, August 25, 2010
631 Genetic variants in COX-2, non-steroidal anti-inflammatory drugs, and breast cancer risk: the Western New York Exposures and Breast Cancer (WEB) Study Breast Cancer Research and Treatment, August 23, 2010
632 Bevacizumab-induced small bowel perforation in a patient with breast cancer without intraabdominal metastases Full Text Investigational New Drugs, August 20, 2010
633 VEGF pathway inhibition by anticancer agent sunitinib and susceptibility to atherosclerosis plaque disruption Full Text Investigational New Drugs, August 20, 2010
634 Genetic polymorphisms associated with 5-fluorouracil-induced neurotoxicity Chemotherapy, August 19, 2010
635 Prognostic impact of bleomycin-induced pneumonitis on the outcome of Hodgkin's lymphoma Annals of Hematology, August 19, 2010
636 Epstein–Barr virus-infected subcutaneous panniculitis-like T-cell lymphoma associated with methotrexate treatment International Journal of Hematology, August 19, 2010
637 Risk assessment in radiation therapy Bulletin du Cancer, August 18, 2010
638 Aspirin and risk of endometrial cancer: a case-control study from Italy European Journal of Cancer Prevention, August 18, 2010
639 Deferasirox for managing transfusional iron overload in people with sickle cell disease Cochrane Reviews, August 17, 2010 Evidence Based Medicine Review Article
640 Hypopharyngeal carcinoma after radiation for tuberculosis: Radiation-induced carcinoma Oral Oncology , August 16, 2010
Clinical Pearls in Oncology
- The ZORO study demonstrated that the addition of goserelin to neoadjuvant chemotherapy for early breast cancer in premenopausal women resulted in no change in post-chemotherapy rates of amenorrhea
- A little over 50% of tumors in women with ER-positive, node-negative breast cancers will have a RS <18, and current data suggests that these women are UNLIKELY to receive a benefit from adjuvant chemotherapy
- In patients with completely resected ER-positive DCIS when the surgical specimen also has LCIS, consider breast MRI screening in addition to mammography due to the lower sensitivity of mammograms for lobular disease
Highlights in Oncology
VEGFR-1 is a prognostic marker for HCC
As reported in the Journal of Pathology, the expression of vascular endothelial growth factor receptor (VEGFR)-1 is elevated in invasive hepatocellular cancer (HCC) specimens. In a study based on 135 HCC specimens, elevated VEGFR-1 was also associated with worse recurrence-free and overall survival.
Read the article summaryHCC risk increased in patients with AIDS
As reported in Cancer, researchers from the NCI have reported that patients with AIDS have a 4-fold increased risk of HCC compared to the general population. The study findings were based on 615,150 patients with AIDS between 1980 and 2009. The risk for HCC in patients with AIDS was essentially the same during the monotherapy/dual therapy and highly active anti-retroviral therapy eras.
Read the article summaryRAB25 is a prognostic marker for ovarian cancer
As reported in the International Journal of Cancer Research and Treatment, the pre-operative level of RAB25 is a predictor of disease-free survival (HR=18.2) and overall survival (HR=33.6) in patients with ovarian cancer. The study involved 36 and 16 women with ovarian cancer and benign tumors, respectively. The pre-operative cell-free DNA of genes (B2M, RAB25, CLDN4, and ABCF2) were measured and RAB25 was shown to be an independent prognostic factor.
Read the article summaryMost Popular Oncology Articles
Last month's top read Top Articles of 20121 Toxicity of Bevacizumab in Combination with Chemotherapy in Older Patients The Oncologist, April 15, 2013 Free full text
2 Malignant Pericardial Effusion Cardiology, April 8, 2013
3 Enalapril And Carvedilol for Preventing Chemotherapy-Induced Left Ventricular Systolic Dysfunction in Patients with Malignant Hemopathies. The OVERCOME Trial JACC - Journal of the American College of Cardiology, April 12, 2013
4 Cardiac Magnetic Resonance Imaging in the Evaluation of the Late Effects of Anthracyclines Among Long-Term Survivors of Childhood Cancer JACC - Journal of the American College of Cardiology, April 5, 2013
5 Evaluation of memory impairment in aging adult survivors of childhood acute lymphoblastic leukemia treated with cranial radiotherapy Journal of the National Cancer Institute, April 18, 2013
6 Bevacizumab and central nervous system (CNS) hemorrhage Cancer Chemotherapy and Pharmacology, April 9, 2013
7 Biomolecular markers of cancer-associated thromboembolism Critical Reviews in Oncology/Hematology, April 2, 2013
8 Risk of postoperative venous thromboembolism after minimally invasive surgery for endometrial and cervical cancer is low: A multi institutional study Gynecologic Oncology, April 24, 2013
9 Brain and Neck Tumors Among Physicians Performing Interventional Procedures The American Journal of Cardiology, April 29, 2013
10 Cetuximab/cisplatin and radiotherapy in HNSCC: is there a favorite choice? Central European Journal of Medicine, April 23, 2013
11 A predictive model for dysphagia following IMRT for head and neck cancer: Introduction of the EMLasso technique Radiotherapy & Oncology, April 26, 2013
12 The Correlation Between Dose of Folinic Acid and Neurotoxicity in Children and Adolescents Treated for Osteosarcoma With High-dose Methotrexate (HDMTX): A Neuropsychological and Psychosocial Study Journal of Pediatric Hematology/Oncology, April 29, 2013
13 Update on antiangiogenic therapy in colorectal cancer: aflibercept and regorafenib Journal of Gastrointestinal Oncology, April 25, 2013 Free full text
14 Toxicities, complications, and clinical encounters during intraperitoneal chemotherapy in 17 women with ovarian cancer European Journal of Oncology Nursing , April 23, 2013
15 Venous thromboembolism in adults treated for acute lymphoblastic leukaemia: Effect of fresh frozen plasma supplementation Thrombosis and Haemostasis, April 23, 2013
16 Cancer cachexia in the age of obesity: skeletal muscle depletion is a powerful prognostic factor, independent of body mass index Journal of Clinical Oncology, April 1, 2013
17 Single-dose Palonosetron and Dose-reduced Regimen of Dexamethasone in Preventing Nausea and Vomiting by Anthracycline-including Chemotherapy in Patients with Early Breast Cancer Anticancer Research, April 10, 2013
18 Identification of clinical predictive factors of oxaliplatin-induced chronic peripheral neuropathy in colorectal cancer patients treated with adjuvant Folfox IV Supportive Care in Cancer, April 3, 2013
19 The impact of chemotherapy-associated neutrophil/ lymphocyte counts on prognosis of adjuvant chemotherapy in colorectal cancer BMC Cancer, April 5, 2013 Free full text
20 Population PK/PD modeling of eltrombopag in subjects with advanced solid tumors with chemotherapy-induced thrombocytopenia Cancer Chemotherapy and Pharmacology, April 10, 2013
Indexed Journals in Oncology: Journal of Clinical Oncology, Cancer Research, Annals Oncology more
Other Topics in Oncology
Register now to view all the MDLinx contents (FREE)!
- Stay current on the latest literature, research and clinical news
- Get special communications and offers from MDLinx and our sponsors
- Receive invitations to paid market research
Login
Stay current - Media Tool
♦ Subscribe to our free RSS feeds:
Get the latest news in your specialty automatically added to your newsreader or your personal My Yahoo!, Google, My MSN or My AOL page. Learn More ♦
♦ Follow Us on Twitter
Twitter is a rich source of instantly updated information. Join today and follow @MDLinx to start receiving tweets. Learn More ♦
Close